Avsar.

Healthcare · Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd (IOLCP)

₹149.22

Mkt cap
₹3,923 Cr
P/E ratio
26.90
P/B
2.43
Div yield
0.75%
ROE
8.38%
ROCE
11.20%
EPS (TTM)
₹5.55
Book value
₹61
52W range
68–174
Sector
Healthcare

IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market. [1] It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35%. [2]

NSE IOLCPBSE 524164www.iolcp.com
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthHigh
TechnicalsBullish
52-week range
−14.13% from high
₹149
₹68+118.77% from low₹174
Current
₹149.22
Prev close
₹149.56
Day
−0.23%
Price performance
1D
−0.23%
1W
−4.00%
1M
+11.64%
3M
+67.46%
6M
+108.58%
1Y
+61.39%
YTD
+77.58%

Financials

F
Revenue, profit & margin
P/E ratio
26.9×
IOLCP is 19% below the sector median of 33.3×
IOLCP26.9×
Sector median33.3×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales587563545520504502526523528552568580619
Expenses491490481476454452484476465490510523527
Operating Profit96736444505142476362575793
OPM %16%13%12%9%10%10%8%9%12%11%10%10%15%
Other Income97788764577-62
Interest5444324444343
Depreciation12141616161718191920202020
Profit before tax88625132383926284546412871
Tax %25%25%26%28%25%24%26%26%30%25%26%25%25%
Net Profit65463823283019213234302153
EPS in Rs2.221.571.290.790.961.010.650.701.081.161.020.701.81
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Mar 2026
57.48%Promoter
Promoters57.48%4.86
FIIs1.72%0.36
DIIs0.02%
Public40.78%4.48
Ownership trend

Peers

P8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,862.8035.824,46,9480.86%2,710+13.58%14,612+12.76%20.53%
Divi's Lab.₹6,713.5067.941,78,2220.45%751+13.44%2,831+9.52%21.96%
Torrent Pharma.₹4,516.2069.741,52,8490.84%364−20.58%4,197+41.84%15.19%
Cipla₹1,440.1030.561,16,3380.90%543−54.61%6,541−2.80%15.49%
Dr Reddy's Labs₹1,350.5026.861,12,7230.59%221−86.14%7,546−11.51%13.64%
Zydus Lifesci.₹1,101.4020.431,10,8270.09%1,341+21.92%7,587+16.22%21.15%
Lupin₹2,343.5018.591,07,1520.51%1,469+101.49%7,475+31.89%30.32%
IOL Chemicals₹133.6626.863,9230.75%53+68.18%619+17.37%11.25%
Median: 157 Co.₹408.3033.251,7980.09%12+22.34%177+16.22%15.14%

Filings

D
Annual reports15
Financial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bseFinancial Year 2015bseFinancial Year 2014bseFinancial Year 2013bseFinancial Year 2012bseFinancial Year 2011bse
Concall transcripts51
TranscriptPPTTranscriptPPTTranscriptPPTTranscriptPPTTranscriptPPTRECTranscriptPPTTranscriptPPTTranscriptPPTRECTranscriptPPTTranscriptPPTTranscriptPPT
Credit ratings6
Rating update 4 Jul 2025careRating update 5 Nov 2024careRating update 28 Jun 2024careRating update 30 Jun 2023careRating update 4 Jul 2022careRating update 6 Jul 2021care
Announcements5
Closure of Trading Window 25 JunAnnouncement under Regulation 30 (LODR)-Newspaper Publication 19 JunCommunication To Shareholders Relating To Unclaimed Dividend 11 Jun - Company notifies shareholders about unclaimed dividends for FY20-26 and requests KYC documents to avoid IEPF transfer.Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 10 Jun - Minor fire at Unit-9B minoxidil plant; no injuries, no major damage, operations suspended 8-10 days.Announcement under Regulation 30 (LODR)-Earnings Call Transcript 28 May